Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Renal Resistive Index (RI) in Predicting Acute Kidney Injury Progression and Need for Renal Replacement Therapy in Patients Followed in the Intensive Care Clinic

NCT06995222 is registered in ClinicalTrials.gov with Gulhane Training and Research Hospital as lead sponsor.

NCT NCT06995222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06995222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Renal Resistive Index (RI) in Predicting Acute Kidney Injury Progression and Need for Renal Replacement Therapy in Patients Followed in the Intensive Care Clinic
Lead sponsor
Gulhane Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2025
Completion date
July 1, 2026
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

akut kidney injury, renal replacement therapy for acute kidney injury in icu